1,1'-Carbonyldiimidazole → N-[3-[N-[3-(4-chlorophenyl)-3-(2-pyridyl)propyl]-N-methylamino]propyl]-N'-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]urea
反応式
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([CH:8]([C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][N:18]=2)[CH2:9][CH2:10][N:11]([CH3:16])[CH2:12][CH2:13][CH2:14][NH2:15])=[CH:4][CH:3]=1.[C:23](N1C=CN=C1)(N1C=CN=C1)=[O:24].[CH3:35][C:36]1[NH:40][CH:39]=[N:38][C:37]=1[CH2:41][S:42][CH2:43][CH2:44][NH2:45]>C(OCC)(=O)C.CO>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([CH:8]([C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][N:18]=2)[CH2:9][CH2:10][N:11]([CH2:12][CH2:13][CH2:14][NH:15][C:23]([NH:45][CH2:44][CH2:43][S:42][CH2:41][C:37]2[N:38]=[CH:39][NH:40][C:36]=2[CH3:35])=[O:24])[CH3:16])=[CH:4][CH:3]=1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
Preparation is effected analogously to Example 63, using 0.8 g (2.5 mmol) of N-[3-(4-chlorophenyl)-3-(2-pyridyl)propyl]-N-methyl-1,3-propanediamine, an equimolar amount of 1,1'-carbonyldiimidazole and 0.5 g (2.9 mmol) of 2-[[(5-methylimidazol-4-yl)methyl]thio]ethaneamine as starting materials. Working up by chromatography (eluant: ethyl acetate/methanol 9+1) analogously to Example 63 yields the purified title compound in the form of a crystalline solid; m.p.(ether): 102°-104° C.; MS (+FAB method): m/z (rel. int.[%])=515 ([M+H]+, 10), 95 (75), 230 (100).
後処理
- customPreparation
- custompurified title compound in the form of a crystalline solid
- custom102°-104° C.
出典と根拠
- ORDレコード
- ord-d657ad86179e43ed94c7cbb76356b6a9
- 出典データセット
- uspto-grants-1993_05
- 特許番号
- US05212187
反応ノート
読み込み中…